Scarica l'app Stockscreener
1.03
1.90%
-0.02
Dopo l'orario di chiusura:
1.02
-0.01
-0.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.05
Aprire:
$1.04
Volume 24 ore:
1.03M
Relative Volume:
0.23
Capitalizzazione di mercato:
$301.07M
Reddito:
-
Utile/perdita netta:
$-63.08M
Rapporto P/E:
-3.8148
EPS:
-0.27
Flusso di cassa netto:
$-72.53M
1 W Prestazione:
-1.90%
1M Prestazione:
+3.00%
6M Prestazione:
+74.58%
1 anno Prestazione:
-11.21%
Intervallo 1D:
$1.02
$1.04
Intervallo di 1 settimana:
$1.00
$1.06
Portata 52W:
$0.515
$1.29
Ocugen Inc Stock (OCGN) Company Profile
Nome
Ocugen Inc
Settore
Industria
Telefono
484-328-4701
Indirizzo
11 GREAT VALLEY PARKWAY, MALVERN, PA
Confronta OCGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.03 | 321.67M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-15 | Iniziato | Maxim Group | Buy |
| 2023-03-01 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Iniziato | Mizuho | Buy |
| 2022-06-15 | Ripresa | ROTH Capital | Buy |
| 2022-06-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Iniziato | Noble Capital Markets | Outperform |
| 2021-06-11 | Downgrade | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Mostra tutto
Ocugen Inc Borsa (OCGN) Ultime notizie
Will Ocugen Inc. benefit from rising consumer demandQuarterly Profit Report & Daily Technical Forecast Reports - khodrobank.com
Does Ocugen Inc. have high return on assetsOptions Play & AI Forecasted Stock Moves - khodrobank.com
Advanced analytics toolkit walkthrough for Ocugen Inc.July 2025 Selloffs & Breakout Confirmation Trade Signals - Newser
What is Ocugen Inc. s 5 year growth outlookJuly 2025 WrapUp & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Is Ocugen Inc. forming a bottoming baseWeekly Risk Report & Risk Controlled Daily Plans - Newser
Is Ocugen Inc. stock a smart retirement pickWeekly Trade Summary & Reliable Price Action Trade Plans - khodrobank.com
Is Ocugen Inc. building a consolidation baseWeekly Stock Summary & Daily Technical Stock Forecast Reports - Newser
What does recent volatility data suggest for Ocugen Inc.Trade Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Real time alert setup for Ocugen Inc. performanceQuarterly Portfolio Report & Trade Opportunity Analysis - Newser
Technical analysis overview for Ocugen Inc. stock2025 Analyst Calls & Weekly High Return Forecasts - Newser
Pattern recognition hints at Ocugen Inc. upsideJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - Newser
Volatility clustering patterns for Ocugen Inc.2025 Bull vs Bear & Stock Portfolio Risk Control - Newser
Are Bears Losing Grip on Ocugen Inc. getLinesFromResByArray error: size == 0 - news-j.co.kr
Buyout Rumor: Is Ocugen Inc. stock overvalued or fairly pricedMarket Trend Review & Safe Entry Zone Tips - khodrobank.com
Carisma Therapeutics stock soars after merger agreement with Ocugen - Investing.com
What candlestick patterns are forming on Ocugen Inc.Trade Ideas & Daily Price Action Insights - Newser
Carisma Therapeutics stock soars after merger agreement with Ocugen By Investing.com - Investing.com UK
What’s next for Ocugen Inc. stock priceQuarterly Risk Review & Technical Entry and Exit Tips - Newser
What’s the MACD signal for Ocugen Inc.Trade Performance Summary & AI Driven Price Forecasts - khodrobank.com
Carisma Therapeutics (CARM) Surges 118% on Merger Spark – What’s Next for This Biotech Cinderella? - AInvest
Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025 - Ocugen
Using data models to predict Ocugen Inc. stock movementJuly 2025 Drop Watch & Community Shared Stock Ideas - Newser
Gene Therapy Pioneer Ocugen Takes Center Stage: CEO to Share FDA Strategy at Global Biotech Forums - Stock Titan
Has Ocugen Inc. found a price floorJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
Ocugen Secures $20 Million in Direct Offering with Janus Henderson - MSN
Can Ocugen Inc. hit a new high this monthTrade Exit Report & Low Drawdown Trading Strategies - Newser
Custom strategy builders for tracking Ocugen Inc.Trade Volume Summary & Advanced Technical Analysis Signals - Newser
Order flow analysis tools used on Ocugen Inc.Weekly Investment Summary & AI Optimized Trade Strategies - Newser
Is Ocugen Inc. forming a reversal patternJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
CEO Change: Can Ocugen Inc. benefit from deglobalizationGap Down & Low Risk Entry Point Guides - khodrobank.com
Applying big data sentiment scoring on Ocugen Inc.Market Movers & Fast Entry Momentum Trade Alerts - Newser
Visual trend scoring systems applied to Ocugen Inc.Fed Meeting & Risk Controlled Stock Pick Alerts - Newser
Analyzing Ocugen Inc. with multi timeframe chartsWeekly Profit Recap & Consistent Growth Equity Picks - Newser
Will Ocugen Inc. bounce back from current supportJuly 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Will Ocugen Inc. continue its uptrendInflation Watch & Free Risk Controlled Daily Trade Plans - Newser
Ocugen Inc Azioni (OCGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):